Evidence of the antiepileptic potential of amiloride with neuropharmacological benefits in rodent models of epilepsy and behavior

Epilepsy and Behavior

Volumn 5, Issue 3, 2004, Pages 322-328

  Ali, Atif ^a   Ahmad, Farhan Jalees ^a   Pillai, K K ^a   Vohora, Divya ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Amiloride; Anticonvulsant; Increasing current electroshock; Memory; Mood; Pentylenetetrazole; Sodium hydrogen exchanger

Indexed keywords

AMILORIDE; PENTETRAZOLE; SODIUM PROTON EXCHANGE PROTEIN; ANTICONVULSIVE AGENT;

ANIMAL BEHAVIOR; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BIOENERGY; BRAIN NERVE CELL; CELL PH; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; ELECTRIC SHOCK; EPILEPSY; FORCED SWIMMING TEST; GRIP STRENGTH; MALE; MEMORY; MODULATION; MOOD; MOTOR PERFORMANCE; MOUSE; NEUROPHARMACOLOGY; NONHUMAN; REGULATORY MECHANISM; RODENT; SEIZURE; SEIZURE THRESHOLD; ANALYSIS OF VARIANCE; ANIMAL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; KINDLING; MAZE TEST; MOTOR ACTIVITY; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SWIMMING; TIME;

AMILORIDE; ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; EPILEPSY; KINDLING, NEUROLOGIC; MALE; MAZE LEARNING; MEMORY; MICE; MOTOR ACTIVITY; PENTYLENETETRAZOLE; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SWIMMING; TIME FACTORS;

EID: 3042673221     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2004.01.005     Document Type: Article

References (35)

1. Blum D.E. New drugs for persons with epilepsy Adv. Neurol. 76 1998 57-81
2. Gupta Y.K. Malhotra J. Antiepilpetic drug therapy in the twenty-first century Indian J. Physiol. Pharmacol. 44 1 2000 8-23
3. Desai C.K. Dikshit R.K. Mansuri S.M. Shah U.H. Comparative evaluation of anticonvulsant activity of calcium channel blockers in experimental animals Indian J. Exp. Biol. 33 1995 931-934
4. Rogawski M.A. Mechanism-specific pathways for new antiepileptic drug discovery Adv. Neurol. 76 1998 11-27
5. Sarro G.D. Spagnolo C. Gareri P. Gallelli L. Sarro A.D. Gabapentin potentiates the antiseizure activity of certain anticonvulsants in DBA/2 mice Eur. J. Pharmacol. 349 1998 179-185
6. Whittingham T.S. Warmann E. Assaf H. Sick T.J. La Manna J.C. Manipulating the intracellular environment of hippocampal slices: pH and high-energy phosphates J. Neurosci. Methods 28 1989 83-91
7. Bonnet U. Bingmann D. Wiemann M. Intracellular pH modulates spontaneous and epileptiform bioelectric activity of hippocampal CA3-neurones Eur. Neuropsychopharmacol. 97 2000 97-103
8. + exchanger J. Membr. Biol. 90 1986 1-12
9. Krapf R. Alpern R.J. Cell pH and transepithelial transport in the renal proximal tubule J. Membr. Biol. 131 1993 1-10
10. Sokolova S. Zhang C.L. Arens J. Khodorov B. Heinemann U. Effects of 5-(N-ethyl-N-isopropyl)-amiloride (EIPA) on different patterns of epileptiform activity in rat temporal cortex slices Neurosci. Res. Commun. 10 1992 171-176
11. Ali A. Pillai K.K. Pal S.N. Effects of folic acid and lamotrigine therapy in some rodent models of epilepsy and behavior J. Pharm. Pharmacol. 55 2003 387-391
12. Loscher W. Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs: IV. Protective indices Epilepsy Res. 9 1991 1-10
13. Kitano Y. Usui C. Takasuna K. Hirohashi M. Nomura M. Increasing current electroshock seizure test: a new method for assessment of anti- and pro-convulsant activities of drugs in mice J. Pharmacol. Toxicol. Methods 35 1996 25-29
14. Marwah R. Pillai K.K. Pal S.N. Effect of fluoxetine alone and in combination with anticonvulsants on the increasing-current electroshock seizure test 1998 Jamia Hamdard University New Delhi, India
15. 3 receptor antagonist, protects against PTZ-induced seizures in mice Life Sci. 66 2000 297-301
16. Porsolt R.D. Bertin A. Jalfre M. Behavioural despair in mice: a primary screening test of antidepressants Arch. Int. Pharmacodyn. Ther. 239 1977 327-336
17. Ragozzino M.E. Pal S.N. Unick K. Stefani M.R. Gold P.E. Modulation of hippocampal acetylcholine release and spontaneous alternation scores by intrahippocampal glucose injections J. Neurosci. 18 4 1998 1595-1601
18. Ghosh M.N. Toxicity studies Ghosh M.N. (Ed.). Fundamentals of Experimental Toxicology 1984 153-158 Scientific Book Agency Calcutta
19. Vohora D. Pal S.N. Pillai K.K. Histamine and selective H3- receptor ligands: a possible role in the mechanism and management of epilepsy Pharmacol. Biochem. Behav. 68 2001 735-741
20. Ali A. Pillai K.K. Pal S.N. Some Neuropsychopharmacological, Biochemical and Drug Interaction Effects of Lamotrigine 2001 Jamia Hamdard University New Delhi
21. Roos A. Boron W. Intracellular pH Physiol. Rev. 61 1981 296-434
22. Aram J.A. Lodge D. Epileptiform activity induced by alkalosis in rat neocortical slices: block by antagonists of N-methyl-d-aspartate Neurosci. Lett. 83 1987 345-350
23. Chesler M. Kaila K. Modulation of pH by neuronal activity Trends Neurosci. 15 1992 396-402
24. Giffard R.G. Monyer H. Christine C.W. Choi D.W. Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygen-glucose deprivation neuronal injury in cortical cultures Brain Res. 506 1990 339-342
25. Xiong Z.Q. Saggau P. Stringer J.L. Activity dependent intracellular acidification correlates with the duration of seizure activity J. Neurosci. 20 2000 1290-1296
26. Puka N. Lehmann A. In vivo acidosis reduces extracellular concentrations of taurine and glutamate in the rat hippocampus J. Neurosci. Res. 37 1994 641-646
27. + exchange antiporter and control of intracellular pH in hippocampal brain slices Brain Res. 731 1996 108-113
28. Chesler M. The regulation and modulation of pH in the nervous system Prog. Neurobiol. 34 1990 401-427
29. + exchangers Physiol. Rev. 77 1997 51-74
30. 22Na influx Eur. J. Pharmacol. 149 1988 97-105
31. Lambert M.V. Robertson M.M. Depression in epilepsy: etiology, phenomenology and treatment Epilepsia 40 Suppl. 10 1999 S21-S47
32. Palaty V. Inhibition of monoamine oxidase by amiloride Can. J. Physiol. Pharmacol. 63 1985 1586-1589
33. Lesser R.P. Luders H. Wyllie E. Dinner D.S. Morris H.H. Mental deterioration in epilepsy Epilepsia 27 Suppl. 2 1986 S105-S123
34. Urcelay E. Ibaretta D. Parrilla R. Ayuso M.S. Martin-Requero A. Enhanced proliferation of lymphoblasts from patients with Alzheimer dementia associated with calmodulin-dependent activation of the NHE Neurobiol. Dis. 8 2001 289-298
35. Loscher W. Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations Epilepsy Res. 2 1988 145-181